Codiak BioSciences, Inc. Total Liabilities and Equity
Codiak BioSciences, Inc. had Total Liabilities and Equity of $134.40 million as of 2022-09-30, per its 10-Q filed 2022-11-03.
Discontinued › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2022-11-03
- 2022-09-30: Liabilities and Equity $134.40M.
- 2022-06-30: Liabilities and Equity $132.71M.
- 2022-03-31: Liabilities and Equity $150.07M.
- 2021-12-31: Liabilities and Equity $171.67M.
| Period end | Liabilities and Equity |
|---|---|
| 2022-09-30 | $134.40M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $132.71M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $150.07M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $171.67M 10-Q · filed 2022-11-03 |
| 2021-09-30 | $158.72M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $175.27M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $191.50M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $151.34M 10-K · filed 2022-03-10 |
| 2020-09-30 | $110.35M 10-Q · filed 2020-11-19 |
| 2019-12-31 | $115.96M 10-K · filed 2021-03-17 |